Next Generation Sequencing Markets (Instrumentation, Consumables, Services, Competitive Analysis, Trends)
The promise of DNA sequencing has attracted many companies, researchers, and investors. The sequencing market is now large and growing rapidly, finding numerous commercial applications in many fields, including clinical diagnostics, drug discovery and development, agriculture, forensics and consumer genomics. Next Generation Sequencing Markets (Instrumentation, Consumables, Services, Competitive Analysis, Trends) provides a market snapshot and a total market forecast, including:
Global Sequencing Market Estimated Breakdown, 2017 (%) (Sanger Sequencing, Next Generation Sequencing)
Global Next Generation Sequencing (NGS) Market Estimated Breakdown, 2017 (%) (Instruments, Consumables, Services)
Worldwide Sequencing Market Product Revenues (Total Market, including Instruments, Consumables, and Services), 2017 and 2022
Global Sequencing Market, 2016-2022 (Sanger Sequencing Technologies, Next Generation Sequencing Technologies, Total)
Global Sequencing Market, 2016-2022 (Sanger Sequencing, Next Generation Sequencing, Total market)
Global NGS Instrumentation Market, 2016-2022
Global NGS Consumables Market, 2016-2022
Global Next Generation Sequencing (NGS) Market, 2016-2022 (Services, Instruments, Consumables, Total market)
Geographic Distribution in NGS Markets
Revenue growth in NGS markets is expected to be driven primarily by the increasing use of this technology in clinical applications, as well as by the growing applications of NGS in numerous other scientific and commercial areas. The report forecasts this growth across geographic regions, including the following data points:
Global NGS Market, Estimated Breakdown by Geographies, 2017 (%) (USA, Germany, UK, China, Others)
Global NGS Market Forecast by Geographic Region ($ millions), 2016-2022 (World, United States, Europe, APAC, Rest of World)
Sequencing Market - Research versus Clinical Use
The initial customers for DNA sequencing platforms were researchers, such as those in academic, government, and other non-profit institutions, as well as pharmaceutical and other companies performing various types of research. DNA sequencing will continue to be widely used by researchers, and the use of sequencing for research applications is expected to continue to grow as the instrumentation becomes more affordable and user-friendly, and scientists become more aware and comfortable with NGS technologies. In addition, as the applications of sequencing are expanding beyond academic research into commercial areas such as clinical diagnostics, consumer genomics, forensics, and agriculture, additional commercial organizations have entered this field. The report reviews the sequencing market in terms of research versus clinical use:
Clinical Sequencing Market (Instrumentation, Consumables, Services, Total), 2017-2022
Research Sequencing Market (Instrumentation, Consumables, Services, Total), 2017-2022
Clinical Sequencing Market - Disease Indications
As the development of NGS-based clinical diagnostics has intensified in recent years, companies active in the NGS market have introduced various solutions to accelerate the development of clinical applications, including sample and library preparation reagent kits optimized for low input and degraded DNA samples, or for types of samples commonly used in clinical practice, such as blood and saliva. Other approaches include technologies that reduce the overall number of steps involved in library preparation, eliminate the sample preparation entirely, enable single tube chemistries, or permit the multiplexing of large numbers of samples. Next Generation Sequencing Markets provides a breakdown of the current clinical sequencing market by disease category:
Estimated Clinical Sequencing Market Breakdown by Disease Category, 2017, Percentage (Oncology, Reproductive health, Rare/inherited disorders, Others)
Projected Clinical Sequencing Market Breakdown by Disease Category, 2022, Percentage (Oncology, Reproductive health, Rare/inherited disorders, Infectious diseases, Others)
Industry Structure and Trends
The global market for NGS technologies has been characterized by a rapid evolution of sequencing technologies and decreasing sequencing prices, which has made NGS more accessible to a growing base of users and affordable for various commercial applications. Also, the global market for NGS technologies is experiencing several notable trends that have a significant effect on its participants, as well as on the overall market growth.
In recent years, the introduction of numerous new products intended for a broad range of applications has expanded and accelerated the adoption of NGS in many fields beyond pure sequencing, including clinical diagnostics, drug development, agriculture, forensics, consumer genomics, and food and pathogen testing. The report outlines NGS industry structure and analyses in detail the relevant trends as well as their estimated impact on market growth, including the following:
NGS Technologies Industry Structure Summary, 2018 (Number and Type of Participating Companies, Key Players, Main Types of Customers, Market Concentration, Key Competitive Factors, Barriers to Entry, Differentiation Strategies, Notable Mergers and Acquisitions)
Significant Trends in the NGS Technologies Market, 2018
More than 100 players participate in NGS markets, from large multinational corporations to small, niche life sciences companies, developing and commercializing various NGS products. Next Generation Sequencing Markets profiles selected players in the market for NGS technologies, including:
10x Genomics, Inc.
Adaptive Biotechnologies Corporation
Agilent Technologies Inc.
Base4 Innovation Ltd
Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
Becton, Dickinson and Company (BD)
Bioo Scientific Corporation
Direct Genomics Co., Ltd.
DNA Electronics Ltd.
Dovetail Genomics, LLC
HTG Molecular Diagnostics
Mission Bio, Inc.
New England Biolabs, Inc.
NuGen Technologies, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
Stratos Genomics Inc.
Takara Bio USA (Clontech Laboratories)
Thermo Fisher Scientific